Show simple item record

dc.contributor.authorLoughnan, SA
dc.contributor.authorNewby, JM
dc.contributor.authorHaskelberg, H
dc.contributor.authorMahoney, A
dc.contributor.authorKladnitski, N
dc.contributor.authorSmith, J
dc.contributor.authorBlack, E
dc.contributor.authorHolt, C
dc.contributor.authorMilgrom, J
dc.contributor.authorAustin, M-P
dc.contributor.authorAndrews, G
dc.date.accessioned2020-12-09T23:04:08Z
dc.date.available2020-12-09T23:04:08Z
dc.date.issued2018-01-22
dc.identifierpii: 10.1186/s13063-017-2422-5
dc.identifier.citationLoughnan, S. A., Newby, J. M., Haskelberg, H., Mahoney, A., Kladnitski, N., Smith, J., Black, E., Holt, C., Milgrom, J., Austin, M. -P. & Andrews, G. (2018). Internet-based cognitive behavioural therapy (iCBT) for perinatal anxiety and depression versus treatment as usual: study protocol for two randomised controlled trials. TRIALS, 19 (1), https://doi.org/10.1186/s13063-017-2422-5.
dc.identifier.issn1745-6215
dc.identifier.urihttp://hdl.handle.net/11343/253134
dc.description.abstractBACKGROUND: We aimed to evaluate the acceptability and efficacy of two brief, Internet-delivered cognitive behavioural therapy interventions-MUMentum Pregnancy (study 1) and MUMentum Postnatal (study 2)-in reducing maternal symptoms of anxiety, depression and overall psychological distress compared to usual care in the perinatal period. METHODS/DESIGN: Women who are pregnant (study 1) or < 12 months postpartum (study 2) with current clinically elevated symptoms of anxiety and/or depression according to validated self-report measures, will be recruited via the research arm of a not-for-profit clinical and research unit in Australia and randomised to the intervention group or treatment as usual control group. The minimum sample size for each study (alpha 0.05; power 0.80 for a g of 0.80) was identified as 50 with at least 10% more to be recruited to account for expected attrition. The co-primary outcome measures are the Patient Health Questionnaire 9-item scale and Generalised Anxiety Disorder 7-item scale to measure depression and anxiety symptom severity, respectively, and will be administered at the following primary time-points: baseline; post treatment; and at one-month follow-up. Psychological distress will be measured according to the Kessler-10 psychological distress scale at each primary time-point and will also be completed before each lesson for those in the intervention group. The total trial period nine weeks for study 1 and 11 weeks for study 2. Program efficacy will be determined using intent-to-treat mixed models. Maintenance of gains will be assessed at one-month follow-up. DISCUSSION: The current randomised controlled trial seeks to extend the literature by evaluating the efficacy of a self-help intervention for women in the perinatal period. If efficacious, the MUMentum programs have the potential to be easily disseminated via https://thiswayup.org.au/ to large numbers of women across Australia as an intervention for women screening positive for anxiety, depressive or distress symptoms during pregnancy or postpartum. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12616000560493 ; ACTRN12616000559415 . Registered on 2nd May 2016.
dc.languageEnglish
dc.publisherBMC
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleInternet-based cognitive behavioural therapy (iCBT) for perinatal anxiety and depression versus treatment as usual: study protocol for two randomised controlled trials
dc.typeJournal Article
dc.identifier.doi10.1186/s13063-017-2422-5
melbourne.affiliation.departmentMelbourne School of Psychological Sciences
melbourne.source.titleTrials
melbourne.source.volume19
melbourne.source.issue1
dc.rights.licenseCC BY
melbourne.elementsid1304271
melbourne.contributor.authorMilgrom, Jeannette
dc.identifier.eissn1745-6215
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record